Guide to oral anticoagulant therapy (Part II) Italian Federation of anticoagulant clinics;Guide sur le traitement anticoagulant par voie orale (2e partie)

Sang Thrombose Vaisseaux

Volumn 10, Issue 6, 1998, Pages 360-373

  Boneu, Bernard ^a   Schved, Jean François ^b  

^a CHU PURPAN   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; COUMADINE; COUMARIN DERIVATIVE; FLUINDIONE; HEPARIN; PHENINDIONE; PROTHROMBIN COMPLEX; TIOCLOMAROL; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BONE MARROW TOXICITY; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; REVIEW; THROMBOEMBOLISM; THROMBOSIS; TREATMENT INDICATION;

EID: 0031819321     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Quick J. The prothrombin time in haemophilia and obstructive jaundice. J Biol Chem 1935 ; 109 : 73-6.
2. Owren PA. Thrombotest : a new method for controlling anticoagulant therapy Lancet 1959 ; ii : 754-8
3. Tripodi A. Le variabili preanalitiche nello studio dell'emostasi. Biochimica Clinica 1989 ; 13 : 441-5.
4. Kirkwood TBL. Calibration of reference thromboplastins Thromb Haemost 1983 ; 49 : 238-44.
5. Chantarangkul V, Tripodi A, Mannucci PM. The effect of instrumentation on the calibration of thromboplastin. Thromb Haemost 1992 ; 67 : 588-9.
6. Poller L, Triplett DA, Hirsh J, Carroll J, Clarke K The value of plasma calibrants in correcting coagulometer effects on international multicenter study. Am J Clin Path 1995 ; 103 : 358-65.
7. Wright IS, Marple CD. Beck DF Anticoagulant therapy of coronary thrombosis with myocardial infarction. JAMA 1948 ; 138 : 1074-9.
8. Azar AJ. Therapeutic achievement with long-term oral anticoagulants in postmyocardial infarction patients. Dissertation. Erasmus University Rotterdam. The Nederlands, 1993.
9. Azar AJ, Deckers IW, Rosendaal FR, et al. Assessment of therapeutic achievement in long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost 1994 ; 72 : 347-351
10. Broekmans AW, Loeliger EA. Therapeutic control of anticoagulant treatment. Br Med J 1982 ; 284 : 1330-1.
11. Dettori AG, Manotti C. Anticoagulanti orali ed antiaggreganti piastrinici nelle protesi valvolan cardiache. G Ital Cardiol 1990 ; 20 : 758-65.
12. Fekkes N, Jonde Hde, Veltkamp JJ, Bieger R, Loeliger EA Comparative study of the clinical effect of acenocoumarol and phenprocoumon in myocardial infarction and angina pectoris. Acta Med Scand 1971 ; 190 : 535-40.
13. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy Thomb Haemost 1993 ; 69 : 236-7.
14. Pattacini C, Manotti C, Pini M, Quintavalla R, Detton AGA. Comparative study on the quality of oral anticoagulant therapy (Warfarin versus Acenocoumarol) Thromb Haemost 1994 ; 71 : 188-91.
15. Cortelazzo S, Finazzi G, Viero P, et al. Qualita' clinica e di laboratorio della terapia anticoagulante orale (traitement anticoagulant oral), prima e dopo l'introduzione di un programma computerizzato Am XI Congr. Naz SISET, Bari 1990 ; n. 193 (abstract).
16. Cortelazzo S, Finazzi G, Viero P, et al. Assessment of computer assisted management of oral anticoagulant therapy. Thromb Haemost 1991 ; 65 : 1219 (abstract).
17. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993 ; 69 : 316-20.
18. Preston FE. Quality control and oral anticoagulant. Thromb Haemost 1995 ; 74 : 515- 20.
19. McInnes GT. Efficacy of anticoagulation in UK. Lancet 1981 ; ii : 88.
20. Duxbury BMD. Therapeutic control of anticoagulant treatment (letter). Br Med J 1982 ; 284 : 1634-5.
21. Weigman H, Vossepoel AMA. Computer program for long term anticoagulant control. Computer Program in Biomedicine 1977 ; 7 : 71-84.
22. Wilson R. James AH Computer assisted management of warfarin treatment. Br Med J 1984 ; 289 : 422-4.
23. Poller R, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993 ; 46 : 299-303.
24. Saetti R, Manotti C, Quintavalla R, Poli T, Dettori AG. L' informatica nel monitoraggio della terapia anticoagulante orale. Esperienza con un programma per personal computer. Atti III Congr Ital Flebologia 1986 ; 673-8.
25. Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990 ; 20 : 119-25.
26. Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest 1992 ; 102 (suppl. 4) : S352-63.
27. Landefeld CS, Beyth RJ. Anticoagulant- related bleeding-clinical epidemiology, prediction, and prevention. Am J Med 1993 ; 95 : 315-28.
28. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy Am J Med 1989 (a) ; 87 : 144-52.
29. Wilcox CM, Truss CD. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988 ; 84 : 683- 90.
30. Landelfeld CS, Rosenblatt MW, Goldman L. Bleeding in outpatients treated with warfarin : relation to the prothrombin time and important remediable lesions. Am J Med 1989(b) ; 87 : 553-9.
31. Levine MN. Nonhemorrhagic complications of anticoagulant therapy. Semin Thromb Hemost 1986 ; 12 : 63-6.
32. Gallerani M, Manfredini R, Moratelli S. Non-haemorrhagic adverse reactions of oral anticoagulant therapy. Int J Cardiol 1995 ; 49 : 1-7.
33. Sheps ES, Gifford RW. Urticaria after administration of warfarin sodium. Am J Cardiol 1959 ; 3 : 118-20.
34. Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis. A review of the literature. Surgery 1988 ; 103 : 271-7.
35. Eby CS. Warfarin-induced skin necrosis. Hematol Oncol Clin North Am 1993 ; 7 : 1291-300.
36. Moreb J, Kitchens CS. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumadin skin necrosis in association with antiphospholipid syndrome : report of two cases Am J Med 1989 ; 87 : 207- 10.
37. Wattiaux MJ, Herve R, Robert A. Cabane J, Housset B, Imbert JC. Coumarin- induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome. Arthritis Rheum 1994 ; 37 : 1096-100.
38. Francis RB, McGehee WG. Defibrination during warfarin therapy in a man with protein C deficiency. Thromb Haemost 1985 ; 53 : 249-51.
39. Feder W, Auerbach R. «Purple toes » an uncommon sequela of oral coumadin drug therapy. Ann Intern Med 1961 ; 55 : 911-7.
40. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robmson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987 ; 82 : 1233-7.
41. Pengo V, Banzato A, Garelli E, Zasso A, Bjasiolo A. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamina Kl) compared with warfarin discontinuation. Blood Coag Fibrinol 1993 ; 4 : 739-41